The FDA has announced that it will not pursue additional enforcement actions against Whoop, a wearable technology company, regarding its blood pressure feature.
This decision comes after Whoop implemented adjustments to the feature, which had previously raised regulatory concerns.
The FDA communicated its decision last week, allowing Whoop to continue its operations without the threat of enforcement.
Updates
Update at 23:36 UTC on 2026-06-23
STAT reported The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood pressure feature.
Sources: STAT